{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:51:23Z","timestamp":1785891083134,"version":"3.56.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2025MS179"],"award-info":[{"award-number":["ZR2025MS179"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22577047"],"award-info":[{"award-number":["22577047"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejmech.2026.119066","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:48:17Z","timestamp":1781308097000},"page":"119066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Novel captopril-valproic acid platinum(IV) hybrids with potent antiproliferative and antimetastatic activities targeting fibrosis and DNA-repair"],"prefix":"10.1016","volume":"316","author":[{"given":"Yan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaiqi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanna","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2093-8237","authenticated-orcid":false,"given":"Qingpeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119066_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13045-025-01660-y","article-title":"Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021","volume":"18","author":"Li","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejmech.2026.119066_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2026.119066_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117788","article-title":"Molecular hybridization strategy - discovery of 2,3-diarylpyrazine derivatives as potent Skp2 inhibitors with improved anti-tumor activity and enhanced cisplatin sensitivity","volume":"295","author":"Hu","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119066_bib4","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","article-title":"Metastasis","volume":"186","author":"Gerstberger","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119066_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","article-title":"Molecular principles of metastasis: a hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2026.119066_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41591-020-01195-4","article-title":"Targeting metastatic cancer","volume":"27","author":"Ganesh","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2026.119066_bib7","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2026.119066_bib8","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1039\/D4DT03162H","article-title":"Autophagy-targeted Pt(IV) agents: a new horizon in antitumor drug development","volume":"54","author":"Li","year":"2025","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2026.119066_bib9","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119066_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100682","article-title":"Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors","volume":"50","author":"Dallavalle","year":"2020","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2026.119066_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.matbio.2023.04.002","article-title":"Tumor-associated fibrosis impairs the response to immunotherapy","volume":"119","author":"Naik","year":"2023","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ejmech.2026.119066_bib12","doi-asserted-by":"crossref","first-page":"11928","DOI":"10.1021\/acs.jmedchem.5c00815","article-title":"Grapefruit extracellular-vesicle-derived nanodrug loading three-functional Platinum(IV) conjugates with enhanced targeting and TME modulating properties","volume":"68","author":"Chen","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119066_bib13","article-title":"Targeting DNA damage and repair machinery via delivering WEE1 inhibitor and platinum (IV) prodrugs to stimulate STING pathway for maximizing chemo-immunotherapy in bladder cancer","volume":"36","author":"Wang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejmech.2026.119066_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101252","article-title":"A novel platinum(IV) prodrug, gramine-Pt(IV) enhances chemoimmunotherapy by activating cGAS-STING and modulating TGF-\u03b2-MHC-I axis","volume":"81","author":"Ding","year":"2025","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2026.119066_bib15","doi-asserted-by":"crossref","first-page":"8296","DOI":"10.1021\/acs.jmedchem.4c00459","article-title":"Tumor-Targeted Oxaliplatin(IV) prodrug delivery based on ROS-Regulated cancer-selective glycan labeling","volume":"67","author":"Wang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119066_bib16","article-title":"Mechanisms of HDACs in cancer development","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2026.119066_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/B978-0-12-394387-3.00003-3","article-title":"HDAC inhibitors: roles of DNA damage and repair","volume":"116","author":"Robert","year":"2012","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119066_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1113966","article-title":"Canagliflozin alleviates valproic acid-induced autism in rat pups: role of PTEN\/PDK\/PPAR-\u03b3 signaling pathways","volume":"14","author":"Elgamal","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119066_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCRESAHA.123.322596","article-title":"TGF-\u03b21\/SMAD3 regulates programmed cell death 5 that suppresses cardiac fibrosis post-myocardial infarction by inhibiting HDAC3","volume":"133","author":"Weng","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejmech.2026.119066_bib20","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12974-018-1193-6","article-title":"Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-\u03baB pathway dependent of HDAC3","volume":"15","author":"Chen","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejmech.2026.119066_bib21","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41416-018-0072-3","article-title":"Suppression of TGF\u03b2-mediated conversion of endothelial cells and fibroblasts into cancer associated (myo)fibroblasts via HDAC inhibition","volume":"118","author":"Kim","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmech.2026.119066_bib22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119066_bib23","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/ijms23020800","article-title":"The epithelial-mesenchymal transition at the crossroads between metabolism and tumor progression","volume":"23","author":"Fedele","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119066_bib24","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2217\/epi-2016-0034","article-title":"Anti-fibrotic effects of valproic acid: role of HDAC inhibition and associated mechanisms","volume":"8","author":"Khan","year":"2016","journal-title":"Epigenomics"},{"key":"10.1016\/j.ejmech.2026.119066_bib25","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3389\/fcell.2020.00732","article-title":"Valproic acid synergizes with Cisplatin and cetuximab in vitro and in vivo in head and neck cancer by targeting the mechanisms of resistance","volume":"8","author":"Iannelli","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2026.119066_bib26","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1349-7006.2008.00793.x","article-title":"Valproic acid resensitizes cisplatin-resistant ovarian cancer cells","volume":"99","author":"Lin","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejmech.2026.119066_bib27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jinorgbio.2013.09.003","article-title":"Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells","volume":"129","author":"Alessio","year":"2013","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2026.119066_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jinorgbio.2014.07.004","article-title":"Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands","volume":"140","author":"Novohradsky","year":"2014","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2026.119066_bib29","doi-asserted-by":"crossref","first-page":"11349","DOI":"10.1039\/D3DT01876H","article-title":"Platinum(IV) combo prodrugs containing cyclohexane-1R,2R-diamine, valproic acid, and perillic acid as a multiaction chemotherapeutic platform for colon cancer","volume":"52","author":"Gabano","year":"2023","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2026.119066_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.trsl.2023.01.005","article-title":"Topical captopril: a promising treatment for secondary lymphedema","volume":"257","author":"Brown","year":"2023","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejmech.2026.119066_bib31","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1007\/s00784-021-04303-x","article-title":"Captopril inhibits matrix metalloproteinase activity and improves dentin bonding durability","volume":"26","author":"Shu","year":"2022","journal-title":"Clin. Oral Invest."},{"key":"10.1016\/j.ejmech.2026.119066_bib32","article-title":"Computational insights into captopril's inhibitory potential against MMP9 and LCN2 in bladder cancer: implications for therapeutic application","volume":"23","author":"Annana","year":"2024","journal-title":"Cancer Inf."},{"key":"10.1016\/j.ejmech.2026.119066_bib33","doi-asserted-by":"crossref","first-page":"17920","DOI":"10.1021\/acs.jmedchem.1c01236","article-title":"Ketoprofen and Loxoprofen Platinum(IV) complexes displaying antimetastatic activities by inducing DNA damage, inflammation suppression and enhanced immune response","volume":"64","author":"Li","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119066_bib34","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1021\/acs.jmedchem.2c01895","article-title":"Development of Clioquinol Platinum(IV) conjugates as autophagy targeted antimetastatic agents","volume":"66","author":"Zhang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119066_bib35","doi-asserted-by":"crossref","first-page":"17551","DOI":"10.1021\/acs.jmedchem.4c01549","article-title":"Ursodeoxycholic acid Platinum(IV) conjugates as antiproliferative and antimetastatic agents: remodel the tumor microenvironment through suppressing JAK2\/STAT3 signaling","volume":"67","author":"Chen","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119066_bib36","doi-asserted-by":"crossref","first-page":"20340","DOI":"10.1021\/acs.jmedchem.5c01395","article-title":"Development of ciprofibrate Platinum(IV) nanodrugs as antimetastatic agents with COFs as carrier","volume":"68","author":"Feng","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119066_bib37","doi-asserted-by":"crossref","first-page":"16416","DOI":"10.1021\/acs.jmedchem.4c01265","article-title":"Transferrin-Modified Carprofen Platinum(IV) nanoparticles as antimetastasis agents with tumor targeting, inflammation inhibition, epithelial\u2212mesenchymal transition suppression, and immune activation properties","volume":"67","author":"Zhang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119066_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2024.112696","article-title":"Ciclopirox Platinum(IV) conjugates suppress tumors by promoting mitophagy and provoking immune responses","volume":"260","author":"Li","year":"2024","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2026.119066_bib39","first-page":"10017","article-title":"The multifaceted influence of histone deacetylases on DNA damage signalling and DNA repair","volume":"44","author":"Roos","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.119066_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","article-title":"A chromatin-mediated reversible drug-tolerant State in cancer cell subpopulations","volume":"141","author":"Sharma","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119066_bib41","doi-asserted-by":"crossref","first-page":"14080","DOI":"10.1021\/acs.jmedchem.3c01120","article-title":"Fighting multidrug resistance with ruthenium-cyclopentadienyl compounds: unveiling the mechanism of P-gp inhibition","volume":"66","author":"Teixeira","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119066_bib42","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1158\/0008-5472.CAN-12-3000","article-title":"Cisplatin resistance associated with PARP hyperactivation","volume":"73","author":"Michels","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119066_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101014","article-title":"Cisplatin-Activated ER\u03b2\/DCAF8 positive feedback loop induces chemoresistance in non-small cell lung cancer via PTEN\/Akt axis","volume":"71","author":"Hu","year":"2023","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2026.119066_bib44","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/sj.bjc.6603914","article-title":"The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model","volume":"97","author":"El-Khoury","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmech.2026.119066_bib45","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12886-023-03046-5","article-title":"Apigenin inhibits angiogenesis in retinal microvascular endothelial cells through regulating of the miR-140-5p\/HDAC3-Mediated PTEN\/PI3K\/AKT pathway","volume":"23","author":"Fu","year":"2023","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.ejmech.2026.119066_bib46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/1756-9966-29-149","article-title":"Effects of valproic acid on the cell cycle and apoptosis through acetylation of histone and tubulin in a scirrhous gastric cancer cell line","volume":"29","author":"Yagi","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119066_bib47","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.canlet.2019.10.013","article-title":"Communication between EMT and PD-L1 Signaling: new insights into tumor immune evasion","volume":"468","author":"Jiang","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2026.119066_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111462","article-title":"CAF-secreted LOX promotes PD-L1 expression via histone lactylation and regulates tumor EMT through TGF\u03b2\/IGF1 signaling in gastric cancer","volume":"124","author":"Li","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2026.119066_bib49","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1021\/acs.molpharmaceut.5c00856","article-title":"Enhancement of targeted and antitumor effects of M1 macrophages based on bioorthogonal reactions","volume":"22","author":"Ding","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2026.119066_bib50","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1021\/mp200597r","article-title":"Conjugate of Pt(IV)-histone deacetylase inhibitor as a prodrug for cancer chemotherapy","volume":"9","author":"Yang","year":"2012","journal-title":"Mol. Pharm."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:15:27Z","timestamp":1785888927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426005118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":50,"alternative-id":["S0223523426005118"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119066","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel captopril-valproic acid platinum(IV) hybrids with potent antiproliferative and antimetastatic activities targeting fibrosis and DNA-repair","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119066"}}